PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease Reportswarts
MeSH D014860 - warts
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D014412:Tumor virus infections
0 Companies
0 Drugs
Success rate
D017193:Viral skin diseases
0 Companies
0 Drugs
Success rate
D030361:Papillomavirus infections
0 Drugs
Success rate
D014860: 
Warts
$
Success rate
D003218:Condylomata acuminata
$
Success rate
D004819:Epidermodysplasia verruciformis
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
Verrica PharmaceuticalsCantharidin Ycanth 2035-05-28 2023-07-21   
Clinical Trials
Historical Success Rate
Phase 1
50%
1/2
Phase 2
17%
2/12
Phase 3
70%
7/10
Approved: 7Overall Success rate: 6%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Merck Sharp & Dohme
Verrica Pharmaceuticals
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use